Healthcare -
Biotechnology - NASDAQ - US
$ 1.24
6.9 %
$ 55.3 M
Market Cap
-0.82
P/E
Price Target
Average
867.74%
Revenue Forecast
Estimate
54.18%
EBIT
Estimate
33.16%
Net Income
Estimate
--17.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Werewolf Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HOWL of $12 , with forecasts ranging from
a
low of
$12 to a high of $12 .
HOWL Lowest Price Target
Wall Street Target
12 USD
867.74%
HOWL Average Price Target
Wall Street Target
12 USD
867.74%
HOWL Highest Price Target
Wall Street Target
12 USD
867.74%
REVENUE FORECAST
Revenue Forecast Chart HOWL
EBIT FORECAST
EBIT Forecast Chart HOWL
NET INCOME FORECAST
Net Income Chart HOWL